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International Study Finds
Breast Milk Free of Significant
Lead Contamination
The recent article by Gulson et al. (1) should
provide reassurance to most women that their
breast milk is free ofsignificant lead contami-
nation. Their data found that breast milk con-
tained lower levels oflead than infant formula
orinfant food. Although small amounts oflead
may be found in all human tissues, the milk of
the vast majority ofwomen does not present a
lead hazard to their babies. Unfortunately, the
authors formed unwarranted conclusions from
their data, and the title of the press release,
"International Study Finds Mothers' Lifetime
Lead Exposures May Put Breast-fed Newborns
at Risk," (2) was misleading. As a result,
women reading this press release may decide
not to breast-feed, thus depriving their babies
of the most healthful food available to them
and placing their infants at increased risk for a
variety ofinfectious diseases. This press release
is in conflict with the decade-old public health
goals to increase both the percentage ofmoth-
ers who breast-feed and duration of breast-
feeding in the United States (3). Why did this
happen? What lessons can we learn from the
chain ofevents that led to the release ofsuch
misinformation? How can we avoid exposing
the public to misinformation that can have
dangerous publichealth consequences?
Gulson et al. (1) examined a small, non-
representative sample of 15 eastern European
women emigrants and their Australian-born
babies (n = 16) and compared them with 6
second-generation Australian women and
their 8 babies. None of the women were
exposed to lead except through background
levels in the diet. The study reported no dif-
ference in either blood lead or breast milk
lead concentrations of European emigrants
versus Australian mothers. All had low blood
lead values [geometric mean (GM) = 2.02
pg/dl; range 0.91-3.61 pg/dl]. They also had
very low levels of lead in their breast milk
(GM = 0.7 pg/kg; range 0.09-2.09 pg/kg),
lower than lead levels in infant formula (GM
= 1.8 pg/kg; range 0.36-4.3 jig/kg) or infant
foods (GM = 4.1 jig/kg; range 1.4-27
pg/kg). The authors reported that maternal
blood isotope ratios and breast milklead con-
centrations predicted infant blood isotope
ratios, although the level ofstatistical signifi-
cance for this analysis (p = 0.09) was, at best,
marginal and the coefficient for infants'
blood lead concentration was negative.
Gulson et al. (1) also estimated the percent-
age ofeach child's blood lead attributable to
breast milk (36-80%) and/or infant formula
(24-68%). The authors did not estimate the
uncertainty surrounding these percentages,
they did not provide data on infants' blood
lead levels, and they did not compare infants'
blood levels related to breast milk and formu-
la. We believe the data of Gulson et al. (1)
suggest that compared with other infants,
breast-fed infants are not at increased risk
from lead poisoning.
The authors' analysis ofpredictors oflead
isotopic ratios is not meaningful in establish-
ing risk for lead poisoning. While the isotopic
ratio may be useful in establishing the source
oflead, it is the mother's body burden oflead
and total blood lead level that influence breast
milk concentrations of lead and, ultimately,
the infant's exposure to lead from breast milk.
Gulson et al. (1) speculate on which
women are highly exposed to lead and then
suggest a public health practice recommenda-
tion of screening women for lead body bur-
dens. While it may be useful to recommend
screening for highly exposed women, we sus-
pect that only a small fraction ofwomen are
highly exposed. Screening recommendations
should accurately target exposed women, such
as those employed in lead-exposed jobs where
blood lead levels are routinely measured and
medical removal already occurs (4). In addi-
tion, action levels at which breast-feeding is
contraindicated must be set before targeted
screening could be made meaningful. No
action level was provided by Gulson et al. A
useful action level must weigh both the risks
and benefits from breast milk. The Health
Resources and Services Administration
(HRSA) has published a blood level action
level of 40 pg/dl or above as a contraindica-
tion for breast-feeding (5). None ofthe 2,925
women 15-44 years of age who participated
in Phase 2 ofthe Third National Health and
Nutrition Examination Survey had a concen-
tration that high, and only two women had
levels even halfthat high (6). The Health and
Human Services Federal Advisory Committee
on the Prevention of Childhood Lead
Poisoning has not considered a recommenda-
tion about screening of women to prevent
lead poisoning in children, but it is the appro-
priate group to do so ifsuch a recommenda-
tion were necessary.
We became aware ofthe study by Gulson
et al. (1) when the Centers for Diseases
Control and Prevention (CDC) received
media inquiries about the NIH press release
describing the article. We were surprised that
the press office would endorse a title that
could discourage women from breast-feeding,
in spite ofwell-established public health goals
to the contrary. We became alarmed after we
examined the article and contrasted the actu-
al data in the report with the authors' conclu-
sions and the press release. Healthy People
2000 set the nation's goal for the proportion
of mothers breast-feeding their infants at
75% during the early postpartum period,
50% through 6 months, and 25% through
the first year of life (3). Because these goals
have not been achieved, they have been
directly adopted into Healthy People 2010.
Informing the public about important scien-
tific findings is valuable, but it is crucial that
the media message be accurate. Just as editors
and press officials mustverify technical infor-
mation with technical experts other than the
authors, so must they verify health policy
guidance with public health experts.
As noted in the draft of Healthy People
2010 (7),
Breast milk is widely acknowledged as the
most complete form of nutrition for infants,
with a range of benefits for infants' health,
growth, immunity, anddevelopment.
Breast-feeding benefits the infant and the
mother. The American Academy ofPediatrics
considers breast-feeding to be the ideal
method offeeding and nurturing infants (8).
The studyby Gulson et al. (1) included avery
small number ofinfant-mother pairs, and any
conclusions drawn from it should be made
cautiously. Their data provided no evidence
that breast-feeding puts children at risk for
lead poisoning. We believe that the authors'
recommendations to screen certain women
for elevated blood lead levels to prevent child-
hood lead poisoning through breast-feeding
are premature. Such recommendations, if
made, should be developed by an appropriate
group who would consider both the benefits
and possible risks from breast-feeding. After
all, babies must be fed something, and all the
evidence, including the report by Gulson et
al. (1), support the axiom "breast is best."
ThomasSinks
RichardJ.Jackson
National Center for Environmental Health
Centers for Disease Control
and Prevention
Atlanta, Georgia
REFERENCES AND NOTES
1. Gulson BL, Jameson CW, Mahaffey KR, Mizon KJ,
Patison N, Law AJ, Korsch MJ, Salter MA.
Relationships of lead in breast milk to lead in blood,
urine, and diet of the infant and mother. Environ
Health Perspect106:667474(1998).
2. International Study Finds Mothers' Lifetime Lead
Exposures May Put Breast-fed Newborns at Risk.
Press Release. NIEHS PR 17-98. Research Triangle
Park, NC:National Institute for Environmental Health
Sciences, 1998.
3. Healthy People 2000. National Health Promotion and
Disease Prevention Objectives. PHS 91-50213.
Washington, DC:US Government Printing Office,
1991.
4. Occupational Safety and Health Standards.
Asbestos. 29CFR§1910.1025(1995).
5. Lawrence RA. A Review ofthe Medical Benefits and
Contraindications to Breastfeeding in the United
States (Maternal and Child Technical Information
Bulletin). Arlington, VA:National Center for
Education in Maternal and Child Health, Health
Resources and Services Administration, 1997.
6. National Center for Health Statistics. Phase 2, Third
A 58 Volume 107, Number 2, February 1999 - Environmental Health PerspectivesCorrespondence
National Health and Nutrition Examination Survey
Data. 1991-1993. Hyattsville, MD:US Department of
Health and Human Services. Machine readable pub-
lic-use data tapes, 1996.
7. Healthy People 2010 Objectives: Draft for Public
Comment. Washington, DC:Office of Disease
Prevention and Health Promotion, 1998.
8. American Academy of Pediatrics Work Group on
Breastfeeding. Breastfeeding and the use of human
milk. Pediatrics 100(6):1035-1039 (1997).
Response: Keeping Abreast of
New Science
Sinks and Jackson take strong issue with a
recent paper in EHP by Gulson et al. (1) on
the biokinetics of lead transfer from maternal
bone and other body lead stores to nursing
infants via human breast milk. I wrote an
invited Research Highlights paper (2) that
accompanied and discussed the larger context
and implications ofGulson et al. While Sinks
andJackson did not include my paper in their
letter, their criticisms apply to a number of
issues addressed in myartide.
Sinks and Jackson would have us believe
Gulson et al. (1) were guilty of a public
health heresywhen the latter noted that there
may be potential risks for nursing infants if
lead intakes via breast milk are elevated
because of elevated long-term maternal lead
exposures. My quantitative lead exposure risk
calculations for nursing infants in Table 1
make it clear that the potential impact of
maternal lead burdens for nursing infants
across a range of maternal blood lead (BPb)
values is not atrivial matter.
The clearly indicated goals of Gulson et
al. (1) were to examine and quantitatively
characterize 1) in vivolead movement in nurs-
ing mothers, specifically bone lead resorption
during lactation and nursing, and 2) the toxi-
cokinetic interplay between endogenous
(bone) and exogenous (diet) lead in thebodies
ofthese mothers as they relate to transport of
maternal lead to breast milk and then to nurs-
ing infants. Their findings document that
bone lead releases can contribute significantly
to breast milk lead and ultimately to infant
lead intake in terms of lead source fractional
input. The breast milk study was the latest in
a published peer-reviewed series by Gulson et
al. that used the method of stable lead iso-
topic ratio analysis to quantify the contribu-
tion of bone lead to BPb and lead in other
metabolic compartments, and the temporal
character ofsuch inputs.
The findings revealed by Gulson et al.,
when examined with the many studies of
breast milk lead levels in lactating and nurs-
ing women, indicate that the toxicokinetic
parameters governing lead transfer at low
concentrations ofBPb to breast milkapply to
other cases where there were or are high
maternal lead exposures. This especially
applies to the ratio ofbreast milk lead to BPb
concentrations, which appears to increase at
higher maternal BPb levels.
Neither the Gulson et al. paper nor my
perspective article engaged in undue specula-
tion about risks to the early infant from lead
exposures arising from quite elevated breast
milk lead concentrations. A comparative
analysis ofthe many studies documenting the
quantitative ratios between maternal BPb and
associated breast milk lead levels readily
shows that 1) as BPb increases, not only does
the amount ofmilk lead increase but the frac-
tional distribution may also increase; and 2)
at high maternal lead exposures sufficient to
produce high maternal BPb levels, mothers
will have breast milk lead that may be prob-
lematic for their infants' lead exposures.
Sinks and Jackson take Gulson et al. to
task for suggesting screening of nursing
mothers, particularly those suspected of past
or present high lead exposures. This is a
peculiar criticism. That lead will enter breast
milk from maternal body lead stores in pro-
portion to the lead exposures in nursing
mothers is far from new information. New
data of Gulson et al. that show a significant
fraction of maternal lead released into breast
milk would be derived from very high bone
lead levels following maternal chronic high
lead exposures merely add a transgenerational
dimension to established phenomena. They
permit one to conclude that such maternal
exposures should be monitored. This is the
only way to identify the extent oflead releas-
es to breast milk and ultimately to infants.
The suggestion is hardly inappropriate.
Sinks andJackson cite a 1997 report from
the government's Health Resources and
Services Administration's (HRSA's) National
Center for Education in Maternal and Child
Health on the medical benefits and con-
traindications for infant breast milk feeding.
The report was authored by an authority on
the topic, Ruth A. Lawrence (3). Lawrence's
report says clearly that in the case oflikely ele-
vated lead exposures, it is advisable to not
only screen children (to presumably include
nursing infants) but to screen mothers as well.
Sinks and Jackson state that Lawrence's
report (3) identified a maternal BPb level of
40 jig/dl as the upper limit ofsafe in terms of
the amount of lead entering breast milk and
amounts of lead ingested by nursing infants.
However, the only citation in Lawrence's
report used as the basis for the ceiling figure of
40 pg/dl is a summary 1994 article in the
Centers for Disease Control and Prevention's
(CDC's) Morbidity and Mortality Weekly
Report (MMWR) on preliminary Phase 1
National Health and Nutrition Examination
Survey (NHANES) III data (4). This MMWR
artide, however, contains no discussion oflead
in breast milk and provides no evidence for
selection ofany particular infant breast-feeding
safety limit in terms ofmaternal BPb. In par-
ticular, it cannot be used to justify 40 pg/dl as
the upper limit of a safe maternal BPb for
nursing mothers. It is also clear that Lawrence
(3) is not comfortable with the use ofa mater-
nal BPb as high as 40 pg/dl. As noted,
Lawrence recommended testing nursing
infants for lead exposure even ifmaternal BPb
concentrations are below 40 pg/dl and to do
environmental lead assessments if maternal
BPb is above 10 pg/dl.
Lawrence (3) also implies that a breast
milk lead level is acceptable if such levels do
not materially add to infant lead burdens.
Specifically, not only would no net accumula-
tion occur if infant lead intake is less than 5
pg/day, but infant lead burdens acquired in
uterowould begin to show net excretion (neg-
ative lead balance) at such lowlead intakes.
Use of the high and obsolete maternal
BPb value of40 pg/dl as the upper limit for
producing safe milk lead content, even if it
were somehow still relevant, raises the obvi-
ous question of what breast milk lead level
would be associated with this maternal BPb
guideline. Lawrence (3) states that breast
milk lead content can typically range up to
15-20% ofthe maternal BPb level. This is a
range consistent with a number of breast
milk lead studies in which BPb levels were
elevated. Selection of 15% as the ratio results
in a breast milk level of60 pg/l (6 pg/dl) for
a maternal BPb of40 pg/dl.
I am not aware ofany published toxicoki-
netic analysis or any other credible quantita-
tive risk assessment of breast milk lead
intakes by nursing infants that would validate
a maternal BPb level of40 pg/dl as the upper
limit ofsafe with regard to resulting lead lev-
els in breast milk and infant BPb levels. I
have carried out an analysis of the 40 pg/dl
BPb value, as part of a series of selected
maternal BPb levels, in terms of resulting
infant BPb levels. The results are in Table 1.
Table 1 presents modeled infant exposures
using the EPA's Integrated Exposure-Uptake
Biokinetic (IEUBK) computer model for this
purpose. This well-validated model is in rou-
tine use by risk assessors (5). The modeling
results provide both geometric mean (GM)
BPb concentrations and the percentages of
these nursing infants, 0-6 months ofage, who
would exceed the CDC action level of 10
pg/dl and exceed the medical intervention,
Class III CDC risk level of 20 pg/dl. Infant
BPb mean levels in Table 1 are model-estimat-
ed from postnatal milk lead intakes plus body
lead at birth from prenatal maternal exposures.
Table 1 shows that the only "safe" level,
in terms of the fraction of infants with >20
pg/dl, would be maternal BPb of 15 pg/dl if
no more than 5% ofinfants are to exceed the
20-ig/dl figure. If the risk management
restriction is no more than 1% to exceed this
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